Characteristics of COVID-19 disease in multiple sclerosis patients

被引：21
|
作者：
Barzegar, Mahdi [1 ,2 ]
Mirmosayyeb, Omid [1 ,2 ,3 ]
Ghajarzadeh, Mahsa [3 ]
Nehzat, Nasim [1 ,3 ]
Vaheb, Saeed [1 ]
Shaygannejad, Vahid [1 ,2 ]
Vosoughi, Reza [4 ]
机构：
[1] Isfahan Univ Med Sci, Isfahan Neurosci Res Ctr, Esfahan, Iran
[2] Isfahan Univ Med Sci, Sch Med, Dept Neurol, Esfahan, Iran
[3] Univ Tehran Med Sci, Universal Council Epidemiol UCE, Univ Sci Educ & Res Network USERN, Tehran, Iran
[4] Univ Toronto, St Michaels Hosp, Multiple Sclerosis Clin, Toronto, ON, Canada
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 45卷
关键词：
D O I：
10.1016/j.msard.2020.102276
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Characteristics of COVID-19 in patients with multiple sclerosis
    Ghadiri, Fereshteh
    Sahraian, Mohammad Ali
    Shaygannejad, Vahid
    Ashtari, Fereshteh
    Langroodi, Hamidreza Ghalyanchi
    Baghbanian, Seyed Mohammad
    Mozhdehipanah, Hossein
    Majdi-Nasab, Nastaran
    Hosseini, Samaneh
    Poursadeghfard, Maryam
    Beladimoghadam, Nahid
    Razazian, Nazanin
    Ayoubi, Saeideh
    Rezaeimanesh, Nasim
    Eskandarieh, Sharareh
    Moghadasi, Abdorreza Naser
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [2] Multiple sclerosis patients and COVID-19
    Mado, Hubert
    Adamczyk-Sowa, Monika
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01):
  • [3] Multiple sclerosis patients and COVID-19
    Hubert Mado
    Monika Adamczyk-Sowa
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57
  • [4] Multiple sclerosis patients and disease management during COVID-19 pandemics
    Ferro, D.
    Costa, A.
    Soares-Dos-Reis, R.
    Seabra, M.
    Pinto, M.
    Martins, B.
    Sousa, C.
    Mendonca, T.
    Guimaraes, J.
    Abreu, P.
    Sa, M. J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 64 - 65
  • [5] Multiple sclerosis patients and the COVID-19 pandemic
    Canzonieri, A. M.
    de Sousa, D.
    de Almeida, B.
    Soares, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 737 - 738
  • [6] Characteristics and Outcome of COVID-19 in Patients with Relapsing Multiple Sclerosis Receiving Ofatumumab
    Cross, Anne H.
    Delgado, Silvia
    Habek, Mario
    Davydovskaya, Maria
    Totolyan, Natalia
    Pingili, Ratnakar
    Mancione, Linda
    Sullivan, Roseanne
    Zalesak, Martin
    Su, Wendy
    Ramanathan, Krishnan
    Montalban, Xavier
    Winthrop, Kevin
    NEUROLOGY, 2021, 96 (15)
  • [7] Clinical Characteristics and Outcomes of Multiple Sclerosis Patients with COVID-19 in Toronto, Canada
    Solomon, Jacqueline
    Jones, Ashley
    Hohol, Marika
    Krysko, Kristen
    Muccilli, Alexandra
    Roll, Alexandra
    Rotstein, Dalia
    Schneider, Raphael
    Selchen, Daniel
    Vosoughi, Reza
    Baral, Stefan D.
    Oh, Jiwon
    NEUROLOGY, 2021, 96 (15)
  • [8] Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, Canada
    Solomon, Jacqueline M.
    Jones, Ashley
    Hohol, Marika
    Krysko, Kristen M.
    Muccilli, Alexandra
    Roll, Alexandra
    Rotstein, Dalia
    Schneider, Raphael
    Selchen, Daniel
    Vosoughi, Reza
    Baral, Stefan D.
    Oh, Jiwon
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 58
  • [9] The risk of disease activity after Covid-19 infection in patients with multiple sclerosis
    Boz, Cavit
    Karahan, Serap
    Boz, Gonulden Aktoz
    Okumus, Aleyna Caglar
    Oral, Ebru
    Usta, Senanur
    Tavlioglu, Sinem
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 837 - 838
  • [10] COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
    Reder, Anthony T.
    Centonze, Diego
    Naylor, Maria L.
    Nagpal, Anjali
    Rajbhandari, Rajani
    Altincatal, Arman
    Kim, Michelle
    Berdofe, Aaron
    Radhakrishnan, Maha
    Jung, Eunice
    Sandrock, Alfred W.
    Smirnakis, Karen
    Popescu, Catrinel
    de Moor, Carl
    CNS DRUGS, 2021, 35 (03) : 317 - 330
12345